Preparation of buffy coat platelet hyperconcentrates treated with Mirasol® Pathogen Reduction Technology and stored in PAS

被引:0
|
作者
de Korte, Dirk [1 ]
Marschner, S. [2 ]
Gouwerok, E. [3 ]
Vlaar, R.
Goodrich, R. [4 ]
机构
[1] Sanquin Blood Bank Reg N W, Amsterdam, Netherlands
[2] Navigant Biotechnol, Lakewood, CO USA
[3] Sanquin Res, Amsterdam, Netherlands
[4] Navigant Biotechnol LLC, Lakewood, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:154A / 154A
页数:1
相关论文
共 50 条
  • [1] Generation of double buffy coat platelet hyperconcentrates treated with mirasol? Pathogen reduction technology and stored in PAS
    de Korte, D.
    [J]. VOX SANGUINIS, 2008, 95 : 278 - 278
  • [2] Analysis of cell quality of platelet hyperconcentrates treated with MIRASOL® pathogen reduction technology and stored in PAS
    Marschner, S.
    Einarson, M.
    Vassallo, R.
    Goodrich, R.
    [J]. VOX SANGUINIS, 2008, 95 : 265 - 265
  • [3] Analysis of platelets treated with Mirasol® Pathogen Reduction Technology and stored in platelet additive solution (PAS)
    Marschner, S.
    Cardigan, R.
    Cookson, P.
    de Korte, Dirk
    Dumont, Larry J.
    Einarson, M.
    Herschel, L.
    Janetzko, K.
    Vassallo, R.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 148A - 148A
  • [4] Analysis of plasma ratio and cell quality of platelet hyperconcentrates treated with mirasol® pathogen reduction technology
    Marschner, S.
    Buytaert-Hoefen, K. A.
    Hovenga, N. A.
    Dumont, D. F.
    Herschel, L. H.
    Roger, J.
    Dumont, L. J.
    Aubuchon, J. P.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2007, 47 (03) : 81A - 81A
  • [5] Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System
    Castrillo, Azucena
    Cardoso, Marcia
    Rouse, Lindsay
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (01) : 44 - 48
  • [6] Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 97A - 98A
  • [7] In Vitro Cell Quality Tests of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 93A - 94A
  • [8] MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATMENT OF ORBISAC BUFFY COAT PLATELETS SUSPENDED IN ADDITIVE SOLUTION
    Maia, S.
    Rio, N.
    Marques, S.
    Rouse, L.
    [J]. VOX SANGUINIS, 2010, 99 : 245 - 246
  • [9] PATHOGEN REDUCTION TECHNOLOGY WITH MIRASOL® FOR THE TREATMENT OF ORBISAC BUFFY COAT PLATELETS IN THE PRESENCE OF DIFFERENT ADDITIVE SOLUTIONS
    Yanez Izquierdo, M.
    Moya San Pedro, A.
    Blanco Penis, L.
    [J]. VOX SANGUINIS, 2010, 99 : 201 - 201
  • [10] In Vitro Evaluation of Platelet Concentrates from Buffy Coat Treated with Two Pathogen Reduction Technology (PRT)
    Castrillo Fernandez, A.
    Arcas Otero, C.
    Diaz Pereira, A.
    Rodriguez Calvo, M.
    [J]. TRANSFUSION, 2011, 51 : 54A - 54A